Previously, the combination of CEA fluid assessment and K-ras mutation analysis levels was confirmed to maximize the diagnostic yield of pancreatic cyst biopsy and improve sensitivity and specificity of cyst classification (14). The gene discussed is KRAS; the disease is cyst.